Molecular Epidemiology of Papillary Thyroid Cancer: In Search of Common Genetic Associations

Jemal A , Siegel R , Ward E , Hao Y , Xu J , Thun MJ . 2009. Cancer statistics, 2009. CA Cancer J Clin, 59:225–249.

Davies L , Welch HG . 2006. Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA, 295:2164–2167.

Chen AY , Jemal A , Ward EM . 2009. Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005. Cancer, 115:3801–3807.

Grubbs EG , Rich TA , Li G , Sturgis EM , Younes MN , Myers JN , Edeiken-Monroe B , Fornage BD , Monroe DP , Staerkel GA , Williams MD , Waguespack SG , Hu MI , Cote G , Gagel RF , Cohen J , Weber RS , Anaya DA , Holsinger FC , Perrier ND , Clayman GL , Evans DB . 2008. Recent advances in thyroid cancer. Curr Prob Surg, 45:156–250.

Canzian F , Amati P , Harach HR , Kraimps JL , Lesueur F , Barbier J , Levillain P , Romeo G , Bonneau D . 1998. A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2. Am J Hum Genet, 63:1743–1748.

McKay JD , Lesueur F , Jonard L , Pastore A , Williamson J , Hoffman L , Burgess J , Duffield A , Papotti M , Stark M , Sobol H , Maes B , Murat A , Kääriäinen H , Bertholon-Grégoire M , Zini M , Rossing MA , Toubert ME , Bonichon F , Cavarec M , Bernard AM , Boneu A , Leprat F , Haas O , Lasset C , Schlumberger M , Canzian F , Goldgar DE , Romeo G . 2001. Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21. Am J Hum Genet, 69:440–446.

Harb WJ , Sturgis EM . 2009. Differentiated thyroid cancer associated with intestinal polyposis syndromes: a review. Head Neck(epub, published online ahead of print, DOI 10.1002/hed.21156).

Musholt TJ , Musholt PB , Petrich T , Oetting G , Knapp WH , Klempnauer J . 2000. Familial papillary thyroid carcinoma: genetics, criteria for diagnosis, clinical features, and surgical treatment. World J Surg, 24:1409–1417.

Shattuck TM , Westra WH , Ladenson PW , Arnold A . 2005. Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma. New Engl J Med, 352:2406–2412.

Goldgar DE , Easton DF , Cannon-Albright LA , Skolnick MH . 1994. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst, 86:1600–1608.

Czene K , Lichtenstein P , Hemminki K . 2002. Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish family-cancer database. Int J Cancer, 99:260–266.

Hou P , Xing M . 2006. Absence of germline mutations in genes within the MAP kinase pathway in familial non-medullary thyroid cancer. Cell Cycle, 5:2036–2039.

Xing M . 2005. The T1799A BRAF mutation is not a germline mutation in familial nonmedullary thyroid cancer. Clin Endocrinol, 63:263–266.

Bastos HN , Antão MR , Silva SN , Azevedo AP , Manita I , Teixeira V , Pina JE , Gil OM , Ferreira TC , Limbert E , Rueff J , Gaspar JF . 2009. Association of polymorphisms in genes of the homologous recombination repair pathway and thyroid cancer risk. Thyroid, 19:1067–1075.

Sturgis EM , Zhao C , Zheng R , Wei Q . 2005. Radiation response genotype and risk of differentiated thyroid cancer: A case-control analysis. Laryngoscope, 115:938–945.

Elisei R , Romei C , Vorontsova T , Cosci B , Veremeychik V , Kuchinskaya E , Basolo F , Demidchik EP , Miccoli P , Pinchera A , Pacini F . 2001. RET/PTC rearrangements in thyroid nodules: Studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults. J Clin Endocrinol Metab, 86:3211–3216.

Hamatani K , Eguchi H , Ito R , Mukai M , Takahashi K , Taga M , Imai K , Cologne J , Soda M , Arihiro K , Fujihara M , Abe K , Hayashi T , Nakashima M , Sekine I , Yasui W , Hayashi Y , Nakachi K . 2008. RET/PTC rearrangements preferentially occurred in papillary thyroid cancer among atomic bomb survivors exposed to high radiation dose. Cancer Res, 68:7176–7182.

Nikiforov YE , Rowland JM , Bove KE , Monforte-Munoz H , Fagin JA . 1997. Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Cancer Res, 57:1690–1694.

Volpato CB , Martinez-Alfaro M , Corvi R , Gabus C , Sauvaigo S , Ferrari P , Bonora E , De Grandi A , Romeo G . 2008. Enhanced sensitivity of the RET proto-oncogene to ionizing radiation in vitro. Cancer Res, 68:8986–8992.

Fenton CL , Lukes Y , Nicholson D , Dinauer CA , Francis GL , Tuttle RM . 2000. The ret/PTC mutations are common in sporadic papillary thyroid carcinoma of children and young adults. J Clin Endocrinol Metab, 85:1170–1175.

Kinashi Y , Sakurai Y , Masunaga S , Suzuki M , Nagata K , Ono K . 2007. Evaluation of micronucleus induction in lymphocytes of patients following boron-neutron-capture-therapy: A comparison with thyroid cancer patients treated with radioiodine. J Radiat Res, 48:197–204.

Xiong P , Zheng R , Wang LE , Bondy ML , Shen H , Borer M , Wei Q , Sturgis EM . 2005. A pilot case-control study of gamma radiation sensitivity and risk of papillary thyroid cancer. Thyroid, 15:94–99.

Sigurdson AJ , Hauptmann M , Alexander BH , Doody MM , Thomas CB , Struewing JP , Jones IM . 2005. DNA damage among thyroid cancer and multiple cancer cases, controls, and long-lived individuals. Mutation Res, 586:173–188.

Adjadj E , Schlumberger M , de Vathaire F . 2009. Germ-line DNA polymorphisms and susceptibility to differentiated thyroid cancer. Lancet Oncol, 10:181–190.

Akulevich NM , Saenko VA , Rogounovitch TI , Drozd VM , Lushnikov EF , Ivanov VK , Mitsutake N , Kominami R , Yamashita S . 2009. Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma. Endocrine Rel Cancer, 16:491–503.

Chiang FY , Wu CW , Hsiao PJ , Kuo WR , Lee KW , Lin JC , Liao YC , Juo SHH . 2008. Association between polymorphisms in DNA base excision repair genes XRCC1, APE1, and ADPRT and differentiated thyroid carcinoma. Clin Cancer Res, 14:5919–5924.

Cybulski C , Gorski B , Huzarski T , Masojc B , Mierzejewski M , Debniak T , Teodorczyk U , Byrski T , Gronwald J , Matyjasik J , Zlowocka E , Lenner M , Grabowska E , Nej K , Castaneda J , Medrek K , Szymanska A , Szymanska J , Kurzawski G , Suchy J , Oszurek O , Witek A , Narod SA , Lubinski J . 2004. CHEK2 is a multiorgan cancer susceptibility gene. Am J Hum Genet, 75:1131–1135.

Dombernowsky SL , Weischer M , Allin KH , Bojesen SE , Tybjoerg-Hansen A , Nordestgaard BG . 2008. Risk of cancer by ATM missense mutations in the general population. J Clin Oncol, 26:3057–3062.

Ho T , Li G , Zhao C , Lu J , Wei Q , Sturgis EM . 2009. Association of XRCC1 polymorphisms and risk of differentiated thyroid carcinoma: a case-control analysis. Thyroid, 19:129–135.

Silva SN , Gil OM , Oliveira VC , Cabral MN , Azevedo AP , Faber A , Manita I , Ferreira TC , Limbert E , Pina JE , Rueff J , Gaspar J . 2005. Association of polymorphisms in ERCC2 gene with non-familial thyroid cancer risk. Cancer Epidemiol Biomarkers Prev, 14:2407–2412.

Siraj AK , Al-Rasheed M , Ibrahim M , Siddiqui K , Al-Dayel F , Al-Sanea O , Uddin S , Al-Kuraya K . 2008. RAD 52 polymorphisms contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population. J Endocrinol Invest, 31:893–899.

Gaspar J , Rodrigues S , Gil OM , Manita I , Ferreira TC , Limbert E , Gonçalves L , Pina JE , Rueff J . 2004. Combined effects of glutathione S-transferase polymorphisms and thyroid cancer risk. Cancer Genet Cytogenet, 151:60–67.

Granja F , Morari J , Morari EC , Correa LAC , Assumpcao LVM , Ward LS . 2004. Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer. Cancer Let, 210:151–157.

Ho T , Li G , Zhao C , Wei Q , Sturgis EM . 2005. RET proto-oncogene polymorphisms/haplotypes and risk of differentiated thyroid cancer: a case-control analysis. Laryngoscope, 115:1035–1041.

Ho T , Zhao C , Zheng R , Liu Z , Wei Q , Sturgis EM . 2006. Glutathione-S-transferase polymorphisms and risk of differentiated thyroid carcinomas: a case-control analysis. Arch Otolaryngol Head Neck Surg, 132:756–761.

Ho T , Li G , Zhao C , Zheng R , Wei Q , Sturgis EM . 2008. Fas single nucleotide polymorphisms and risk of thyroid and salivary gland carcinomas: a case-control analysis. Head Neck, 30:297–305.

Morari EC , Leite JL , Granja F , da Assumpcao LV , Ward LS . 2002. The null genotype of glutathione s-transferase M1 and T1 locus increases the risk for thyroid cancer. Cancer Epidemiol Biomarkers Prev, 11:1485–1488.

Rogounovitch TI , Saenko VA , Ashizawa K , Sedliarou IA , Namba H , Abrosimov AY , Lushnikov EF , Roumiantsev PO , Konova MV , Petoukhova NS , Tchebotareva IV , Ivanov VK , Chekin SY , Bogdanova TI , Tronko MD , Tsyb AF , Thomas GA , Yamashita S . 2006. TP53 codon 72 polymorphism in radiation-associated human papillary thyroid cancer. Oncol Rep, 15:949–956.

Gudmundsson J , Sulem P , Gudbjartsson DF , Jonasson JG , Sigurdsson A , Bergthorsson JT , He H , Blondal T , Geller F , Jakobsdottir M , Magnusdottir DN , Matthiasdottir S , Stacey SN , Skarphedinsson OB , Helgadottir H , Li W , Nagy R , Aguillo E , Faure E , Prats E , Saez B , Martinez M , Eyjolfsson GI , Bjornsdottir US , Holm H , Kristjansson K , Frigge ML , Kristvinsson H , Gulcher JR , Jonsson T , Rafnar T , Hjartarsson H , Mayordomo JI , de la Chapelle A , Hrafnkelsson J , Thorsteinsdottir U , Kong A , Stefansson K . 2009. Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet, 41:460–464.